99mTc-Ark

锝[99mTc]肼基烟酰胺双链Ark肽

Report date: 2025/11/28 15:16:47

NME

Base Information

Drug Name99mTc-Ark

Drug Alias NameN/A

ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Nuclides > Technetium > 99mTcSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[5]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDiagnostic agentsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesGuangdong Ridio Technology Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangdong Ridio Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsDiagnostic agentsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A